These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22294418)

  • 1. Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.
    Franzmann EJ; Reategui EP; Pereira LH; Pedroso F; Joseph D; Allen GO; Hamilton K; Reis I; Duncan R; Goodwin WJ; Hu JJ; Lokeshwar VB
    Head Neck; 2012 May; 34(5):687-95. PubMed ID: 22294418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.
    Pereira LH; Adebisi IN; Perez A; Wiebel M; Reis I; Duncan R; Goodwin WJ; Hu JJ; Lokeshwar VB; Franzmann EJ
    Cancer Biomark; 2011; 10(5):241-9. PubMed ID: 22699785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Stratification System for Oral Cancer Screening.
    Pereira LH; Reis IM; Reategui EP; Gordon C; Saint-Victor S; Duncan R; Gomez C; Bayers S; Fisher P; Perez A; Goodwin WJ; Hu JJ; Franzmann EJ
    Cancer Prev Res (Phila); 2016 Jun; 9(6):445-55. PubMed ID: 27020654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
    Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.
    Lallemant B; Evrard A; Combescure C; Chapuis H; Chambon G; Raynal C; Reynaud C; Sabra O; Joubert D; Hollande F; Lallemant JG; Lumbroso S; Brouillet JP
    BMC Cancer; 2009 Oct; 9():370. PubMed ID: 19835631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients.
    Cohen ER; Reis IM; Gomez-Fernandez C; Smith D; Pereira L; Freiser ME; Marotta G; Thomas GR; Sargi ZB; Franzmann EJ
    Oral Oncol; 2020 Jul; 106():104720. PubMed ID: 32325304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels.
    Bell EB; Reis IM; Cohen ER; Almuhaimid T; Smith DH; Alotaibi F; Gordon C; Gomez-Fernandez C; Goodwin WJ; Franzmann EJ
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33530399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.
    Lechner SC; Pereira L; Reategui E; Gordon C; Byrne M; Hooper MW; Lee DJ; Abouyared M; Franzmann E
    J Racial Ethn Health Disparities; 2015 Mar; 2(1):62-7. PubMed ID: 26863242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals.
    Raslan S; Smith DH; Reis IM; Peifer SJ; Forman G; Ezeh UC; Joshi P; Koester M; Buitron I; Al-Awady A; Halgowich J; Liu H; Gordon C; Hooper MW; Sweeny L; Franzmann EJ
    BMC Oral Health; 2024 Jul; 24(1):820. PubMed ID: 39030509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
    Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.
    Baik FM; Hansen S; Knoblaugh SE; Sahetya D; Mitchell RM; Xu C; Olson JM; Parrish-Novak J; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):330-8. PubMed ID: 26892902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of CD44 and its ligand low molecular weight hyaluronan in plasma of HNSCC patients: clinical significance.
    Roy R; Chatterjee N; Khan MS; Sultana F; Roy A; Naskar S; Guha R; Sen S; Chakrabarti J; Chatterjee BP; Panda CK; Dutta S
    Mol Biol Rep; 2024 Jan; 51(1):157. PubMed ID: 38252332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
    Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
    Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines].
    Pries R; Wittkopf N; Hasselbacher K; Wollenberg B
    HNO; 2008 Apr; 56(4):461-6. PubMed ID: 18368378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Levels of Soluble CD44 in a High-Risk Population following a Smoking Cessation Program.
    Smith DH; Raslan S; Reis IM; Al-Awady A; Buitron I; Perez M; Liu H; Halgowich J; Gordon C; Webb Hooper M; Barengo NC; Franzmann EJ
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.